Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optimize EP is a private digital health company focused on cardiology and electrophysiology workflow optimization rather than therapeutic drug development. Founded in 2018, the company offers CaRM, a cloud-based software platform for cardiac device remote monitoring, reimbursement, and billing. Its product is designed to consolidate and simplify data from multiple cardiac devices to improve operational efficiency for electrophysiology and cardiology practices. Optimize EP appears to be commercially active and positioned as a healthcare IT and remote monitoring vendor serving provider organizations. The business is best characterized as a digital health and cardiology data-management company rather than a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optimize EP.